|
Synthetic selective inhibitors of coagulation factor Xa strongly inhibit thrombin generation without affecting initial thrombin forming time necessary for platelet activation in hemostasis.
J Thromb Haemost. 2004 Abr; 2(4):612-8.
Ieko M, Tarumi T, Takeda M, Naito S, Nakabayashi T, Koike T |
|
Anticoagulation in the antiphospholipid syndrome.
Haematologica. 2004 Abr; 89(4):504-3.
Casais P, Alberto MF, Gennari LC, Grosso SH, Meschengieser SS, Lazzari MA |
|
Elevated coagulation factor VIII and the risk for recurrent early pregnancy loss.
Thromb Haemost. 2004 Abr; 91(4):694-9.
Dossenbach-Glaninger A, Van Trotsenburg M, Krugluger W, Dossenbach MR, Oberkanins C, Huber J, Hopmeier P. |
|
Patient-specific errors in agreement between International Normalized Ratios measured by a whole blood coagulometer and by a routine plasma-based method.
Haematologica. 2004 Abr; 89(4):504-5.
Attermann J, Andersen NT, Korsgaard H, Maegaard M, Hasenkam JM |
|
Beta 2-Glycoprotein I binds factor XI and inhibits its activation by thrombin and factor XIIa: loss of inhibition by clipped beta 2-glycoprotein I
Proc Natl Acad Sci U S A. 2004 Mar; 101(11):3939-44.
Shi T, Iverson GM, Qi JC, Cockerill KA, Linnik MD, Konecny P, Krilis SA. |
|
Exosite occupation by heparin enhances the reactivity of blood coagulation factor IXa
Biochemistry. 2004 Mar; 43(10):2978-86.
Neuenschwander PF |
|
Cause-effect relation between hyperfibrinogenemia and vascular disease
Blood. 2004 Mar; 103(5):1728-34.
Kerlin B, Cooley BC, Isermann BH, Hernandez I, Sood R, Zogg M, Hendrickson SB, Mosesson MW, Lord S, Weiler H |
|
Genetics of fibrin clot structure: a twin study
Blood. 2004 Mar; 103(5):1735-40. Epub 2003 Nov 6
Dunn EJ, Ariens RA, de Lange M, Snieder H, Turney JH, Spector TD, Grant PJ. |
|
Recombinant factor VIIa reverses the anticoagulant effect of the long-acting pentasaccharide idraparinux in healthy volunteers.
Br J Haematol. 2004 Mar; 124(5):653-8.
Bijsterveld NR, Vink R, Van Aken BE, Fennema H, Peters RJ, Meijers JC, Buller HR, Levi M |
|
Thrombin Up-regulates Tissue Factor Pathway Inhibitor-2 Synthesis through a Cyclooxygenase-2-dependent, Epidermal Growth Factor Receptor-independent Mechanism
J Biol Chem. 2004 Feb; 279(7):5200-6.
Véronique Neaud, Jennifer Gillibert Duplantier, Claire Mazzocco, Walter Kisiel, and Jean Rosenbaum |
|
Formation of factors IXa and Xa by the extrinsic pathway: Differential regulation by tissue factor pathway inhibitor and antithrombin III.
J Biol Chem. 2004 Feb; Epub ahead of print Nov
Lu G, Broze GJ, Krishnaswamy S |
|
High plasma levels of factor VIII and risk of recurrence of venous thromboembolism
Br J Haematol. 2004 Feb; 124(4):504-10.
Cristina L, Benilde C, Michela C, Mirella F, Giuliana G, Gualtiero P |
|
Rapid generation of thrombin by atheroma and platelets
J Thromb Haemost. 2004 Feb; 2(2):321-6.
Niemetz J, Fallon JT, Harrington E, Hathcock J |
|
Titre of anti-heparin/PF4-antibodies and extent of in vivo activation of the coagulation and fibrinolytic systems.
Thromb Haemost. 2004 Feb; 91(2):381-7.
Oldgren J, Siegbahn A, Grip L, Linder R, Thygesen K, Wallentin L. |
|
Myocardial damage, coagulation activity and the response to thrombin inhibition in unstable coronary artery disease.
Thromb Haemost. 2004 Feb; 91(2):381-7.
Oldgren J, Siegbahn A, Grip L, Linder R, Thygesen K, Wallentin L. |
|
Coagulopathy of sepsis.
Thromb Haemost. 2004 Feb; 91(2):213-24.
Dempfle CE. |
|
Sustained elevated amounts of circulating procoagulant membrane microparticles and soluble GPV after acute myocardial infarction in diabetes mellitus.
Thromb Haemost. 2004 Feb; 91(2):345-53.
Morel O, Hugel B, Jesel L, Lanza F, Douchet MP, Zupan M, Chauvin M, Cazenave JP, Freyssinet JM, Toti F. |
|
Standardization of the endogenous thrombin potential measurement: how to minimize the effect of residual platelets in stored plasma.
Br J Haematol.. 2004 Feb; 124(3):355-7.
Chantarangkul V, Clerici M, Bressi C, Tripodi A |
|
Unique in Vivo Modifications of Coagulation Factor V Produce a Physically and Functionally Distinct Platelet-derived Cofactor: CHARACTERIZATION OF PURIFIED PLATELET-DERIVED FACTOR V/Va.
J Biol Chem. 2004 Ene; 279(4):2383-93. Epub 2003 Oct 31
Gould WR, Silveira JR, Tracy PB. |
|
Effect of abciximab on prothrombin activation and thrombin generation in patients with acute myocardial infarction also receiving reteplase.
Am J Cardiol. 2004 Ene; 93(2):195-8.
Merlini PA, Repetto A, Andreoli AM, Ricci S, Lombardi A, Finardi A, Dipasquale G, Lamponi M, Mannucci PM, Ardissino D. |
